Andrew Scott lab

Our laboratory focuses on the targeting and molecular imaging of tumors and exploring receptor-based signaling pathways responsible for cancer cell growth. We are pursuing immunological approaches to enhancement of cell-killing mechanisms of recombinant antibodies, as well as clinical trials of novel antibodies, small molecules and imaging ligands.